Ghost Tree Capital, LLC Obs Eva Sa Transaction History

Ghost Tree Capital, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 14, 2019	SELL	$10.05 - $14.25 $2.01 Million - $2.85 Million	-200,000 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$11.82 - $14.48 $4.14 Million - $5.07 Million	-350,000 Reduced 63.64%	200,000 $2.56 Million
Q4 2018 Feb 14, 2019	BUY	$10.8 - $17.94 $162,000 - $269,100	15,000 Added 2.8%	550,000 $6.96 Million
Q3 2018 Nov 14, 2018	BUY	$10.92 - $18.18 $1.47 Million - $2.45 Million	135,000 Added 33.75%	535,000 $9.65 Million
Q1 2018 May 15, 2018	SELL	$9.36 - $15.22 $2.03 Million - $3.3 Million	-217,100 Reduced 35.18%	400,000 $5.4 Million
Q4 2017 Feb 14, 2018	BUY	$8.48 - $12.0 $5.23 Million - $7.41 Million	617,100	617,100 $6.02 Million

88K

Ticker OBSV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,499,200
Description
ObsEva SA, a biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for women suffering from reproductive health and pregnancy. It is developing Linzagolix, an oral gonadotropin releasing hormone receptor antagonist that is in Phase III clinical trial for the treatment of pain associated with endometrio...

Get notified when there are updates to the investment portfolio of Ghost Tree Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Ghost Tree Capital, LLC with notifications on news.